retatrutide clinical trial results 2025 First phase 3 data for are here folks. This drug is a barn burner. This was only 68 weeks and was geared towards osteoarthritis of the knee. Massive pain improvements and Retatrutide clinical trial done! Now
Description
Figure 2 GLP-1 and GLP-1 Analogs In patients with T2D, GLP-1 and GLP-1 analogs were shown to improve cardiovascular-risk profiles, by reducing body fat content, blood pressure, circulating lipids, and inflammatory markers (76)
Fingers crossed!
In TRIUMPH-1, participants on 12 mg lost an average of 28.3% of their body weight approximately 70 pounds over 80 weeks
Survey of Ophthalmology
doi: 10.2337/db22-729-P
